Literature DB >> 14511573

Adaptation of cell lines to serum-free culture medium.

S Ozturk1, G Kaseko, T Mahaworasilpa, H G L Coster.   

Abstract

The optimum conditions to allow proliferation of cells for the secretion of some growth factors and cytokines and the proliferation of cells in different media that do not contain proteins or serum from animals (serum-free media) were investigated. The culture of cell lines for the commercial production of products involves optimisation of cell proliferation and secretion in media from which the requisite proteins can be economically extracted. Some of these problems were addressed in this study. We used two different clones from a human myeloma cell line for adaptation to serum free medium in order to characterize long-term effects of the new medium. We gradually decreased serum content of medium and the results showed that cell mortality increased with serum reduction, antibody production lost by survived clones, and secretion of cytokines were always retained.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511573     DOI: 10.1089/153685903322329009

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  3 in total

1.  Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells.

Authors:  François Lefloch; Bertrand Tessier; Sébastien Chenuet; Jean-Marc Guillaume; Pierre Cans; Jean-Louis Goergen; Annie Marc
Journal:  Cytotechnology       Date:  2006-12-29       Impact factor: 2.058

2.  Mammalian Cell Culture as a Platform for Veterinary Vaccines.

Authors:  Thailín Lao González; Ileanet Ávalos Olivera; Alina Rodríguez-Mallon
Journal:  Methods Mol Biol       Date:  2022

3.  The Effects of Serum Removal on Gene Expression and Morphological Plasticity Markers in Differentiated SH-SY5Y Cells.

Authors:  Alix C Thomson; Teresa Schuhmann; Tom A de Graaf; Alexander T Sack; Bart P F Rutten; Gunter Kenis
Journal:  Cell Mol Neurobiol       Date:  2021-03-03       Impact factor: 4.231

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.